James Christensen
2018
In 2018, James Christensen earned a total compensation of $3.2M as Executive Vice President and Chief Scientific Officer at Mirati Therapeutics, a 362% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $247,200 |
|---|---|
| Option Awards | $2,571,375 |
| Salary | $374,385 |
| Other | $2,500 |
| Total | $3,195,460 |
Christensen received $2.6M in option awards, accounting for 80% of the total pay in 2018.
Christensen also received $247.2K in non-equity incentive plan, $374.4K in salary and $2.5K in other compensation.
Rankings
In 2018, James Christensen's compensation ranked 3,608th out of 14,244 executives tracked by ExecPay. In other words, Christensen earned more than 74.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,608 out of 14,244 | 75th |
Division Manufacturing | 1,333 out of 5,759 | 77th |
Major group Chemicals And Allied Products | 470 out of 2,122 | 78th |
Industry group Drugs | 389 out of 1,811 | 79th |
Industry Pharmaceutical Preparations | 300 out of 1,385 | 78th |
Source: SEC filing on April 19, 2019.
Christensen's colleagues
We found four more compensation records of executives who worked with James Christensen at Mirati Therapeutics in 2018.
2018
Charles Baum
Mirati Therapeutics
Chief Executive Officer
2018
Chris LeMasters
Mirati Therapeutics
Executive Vice President and Chief Business Officer
2018
Isan Chen
Mirati Therapeutics
Executive Vice President and Chief Medical and Development Officer
2018
Jamie Donadio
Mirati Therapeutics